Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

The patient who reports a drug allergy.

Ferner R, McGettigan P.

BMJ. 2020 Jan 14;368:l6791. doi: 10.1136/bmj.l6791. No abstract available.

PMID:
31937572
2.

Medical Devices: Definition, Classification, and Regulatory Implications.

Aronson JK, Heneghan C, Ferner RE.

Drug Saf. 2019 Dec 16. doi: 10.1007/s40264-019-00878-3. [Epub ahead of print]

PMID:
31845212
3.

Medical Devices: Classification and Analysis of Faults Leading to Harms.

Ferner RE, Aronson JK.

Drug Saf. 2019 Nov 5. doi: 10.1007/s40264-019-00879-2. [Epub ahead of print]

PMID:
31691257
4.

A novel approach to support implementation of biosimilars within a UK tertiary hospital.

Saxby K, Sanghvi S, Bodalia PN, Ferner RE, Leandro M, Urquhart R, Sofat R.

Br J Clin Pharmacol. 2019 Oct 29. doi: 10.1111/bcp.14150. [Epub ahead of print]

PMID:
31663154
5.

Efficacy and toxicity of antihypertensive pharmacotherapy relative to effective dose 50.

Dimmitt SB, Stampfer HG, Martin JH, Ferner RE.

Br J Clin Pharmacol. 2019 Oct;85(10):2218-2227. doi: 10.1111/bcp.14033. Epub 2019 Aug 19. Review.

PMID:
31219198
6.

Susceptibility to adverse drug reactions.

Ferner R, Aronson J.

Br J Clin Pharmacol. 2019 Oct;85(10):2205-2212. doi: 10.1111/bcp.14015. Epub 2019 Jul 17. Review.

PMID:
31169324
7.

Antithrombotic dose: Some observations from published clinical trials.

Dimmitt SB, Floyd CN, Ferner RE.

Br J Clin Pharmacol. 2019 Oct;85(10):2194-2197. doi: 10.1111/bcp.13968. Epub 2019 Jul 1. Review.

PMID:
31050833
8.

The relationship between antemortem and postmortem morphine concentrations.

Langford NJ, Morley SR, Ferner RE.

Clin Toxicol (Phila). 2019 Dec;57(12):1142-1145. doi: 10.1080/15563650.2019.1591430. Epub 2019 Mar 23.

PMID:
30905172
9.

Adverse drug reactions.

Ferner RE, McGettigan P.

BMJ. 2018 Nov 6;363:k4051. doi: 10.1136/bmj.k4051. No abstract available. Erratum in: BMJ. 2018 Nov 12;363:k4777.

PMID:
30401691
10.

Preventing Future Deaths from Medicines: Responses to Coroners' Concerns in England and Wales.

Ferner RE, Ahmad T, Babatunde Z, Cox AR.

Drug Saf. 2019 Mar;42(3):445-451. doi: 10.1007/s40264-018-0738-z.

PMID:
30298309
11.

Prescribing biosimilars.

Aronson JK, Goldacre B, Ferner RE.

BMJ. 2018 Jul 24;362:k3141. doi: 10.1136/bmj.k3141. No abstract available.

PMID:
30042142
12.

Deaths from Medicines: A Systematic Analysis of Coroners' Reports to Prevent Future Deaths.

Ferner RE, Easton C, Cox AR.

Drug Saf. 2018 Jan;41(1):103-110. doi: 10.1007/s40264-017-0588-0.

PMID:
28808959
13.

Unlicensed and off-label uses of medicines: definitions and clarification of terminology.

Aronson JK, Ferner RE.

Br J Clin Pharmacol. 2017 Dec;83(12):2615-2625. doi: 10.1111/bcp.13394. Epub 2017 Sep 26. Review.

14.

The toxicological significance of post-mortem drug concentrations in bile.

Ferner RE, Aronson JK.

Clin Toxicol (Phila). 2018 Jan;56(1):7-14. doi: 10.1080/15563650.2017.1339886. Epub 2017 Jul 6. Review.

PMID:
28681613
15.

Biomarkers-A General Review.

Aronson JK, Ferner RE.

Curr Protoc Pharmacol. 2017 Mar 17;76:9.23.1-9.23.17. doi: 10.1002/cpph.19. Review.

PMID:
28306150
16.

A systematic review of the evidence for acute tolerance to alcohol - the "Mellanby effect".

Holland MG, Ferner RE.

Clin Toxicol (Phila). 2017 Jul;55(6):545-556. doi: 10.1080/15563650.2017.1296576. Epub 2017 Mar 9. Review.

PMID:
28277803
17.

PCSK9 inhibitors for hypercholesterolaemia.

McGettigan P, Ferner RE.

BMJ. 2017 Jan 19;356:j188. doi: 10.1136/bmj.j188. No abstract available.

PMID:
28104607
18.

Manslaughter trials ignore systemic failures.

Ferner RE.

BMJ. 2016 Dec 30;355:i6630. doi: 10.1136/bmj.i6630. No abstract available.

PMID:
28039121
19.

Perceptions and Impact of Mandatory eLearning for Foundation Trainee Doctors: A Qualitative Evaluation.

Brooks HL, Pontefract SK, Vallance HK, Hirsch CA, Hughes E, Ferner RE, Marriott JF, Coleman JJ.

PLoS One. 2016 Dec 22;11(12):e0168558. doi: 10.1371/journal.pone.0168558. eCollection 2016.

20.
21.

How similar are biosimilars?

Aronson JK, Ferner RE.

BMJ. 2016 May 17;353:i2721. doi: 10.1136/bmj.i2721. No abstract available.

PMID:
27188872
22.
23.

Authors' reply to Green and colleagues.

Ferner RE, Gogtay NJ.

BMJ. 2015 Dec 9;351:h6588. doi: 10.1136/bmj.h6588. No abstract available.

PMID:
26655828
24.

Mefloquine for malarial prophylaxis in military personnel.

Gogtay NJ, Ferner RE.

BMJ. 2015 Nov 3;351:h5797. doi: 10.1136/bmj.h5797. No abstract available.

PMID:
26534919
25.

Cato Guldberg and Peter Waage, the history of the Law of Mass Action, and its relevance to clinical pharmacology.

Ferner RE, Aronson JK.

Br J Clin Pharmacol. 2016 Jan;81(1):52-5. doi: 10.1111/bcp.12721. Epub 2015 Oct 22. Review.

26.

The law of mass action and the pharmacological concentration-effect curve: resolving the paradox of apparently non-dose-related adverse drug reactions.

Aronson JK, Ferner RE.

Br J Clin Pharmacol. 2016 Jan;81(1):56-61. doi: 10.1111/bcp.12706. Epub 2015 Oct 26. Review.

27.

A licence to cure.

Aronson JK, Ferner RE.

BMJ. 2015 Apr 1;350:h1723. doi: 10.1136/bmj.h1723. No abstract available.

PMID:
25834026
28.

A systematic review and meta-analysis of thiazide-induced hyponatraemia: time to reconsider electrolyte monitoring regimens after thiazide initiation?

Barber J, McKeever TM, McDowell SE, Clayton JA, Ferner RE, Gordon RD, Stowasser M, O'Shaughnessy KM, Hall IP, Glover M.

Br J Clin Pharmacol. 2015 Apr;79(4):566-77. doi: 10.1111/bcp.12499.

29.

Temporal and other factors that influence the time doctors take to prescribe using an electronic prescribing system.

Coleman JJ, Hodson J, Thomas SK, Brooks HL, Ferner RE.

J Am Med Inform Assoc. 2015 Jan;22(1):206-12. doi: 10.1136/amiajnl-2014-002822. Epub 2014 Jul 29.

30.

Fundamentals of lung auscultation.

Coleman JJ, Ferner RE.

N Engl J Med. 2014 May 22;370(21):2052. doi: 10.1056/NEJMc1403766. No abstract available.

PMID:
24849096
31.

A fat chance of slimming.

Ferner R.

BMJ. 2013 Dec 10;347:f7389. doi: 10.1136/bmj.f7389. No abstract available.

PMID:
24326891
32.

Checklist for standardized reporting of drug-drug interaction management guidelines.

Floor-Schreudering A, Geerts AF, Aronson JK, Bouvy ML, Ferner RE, De Smet PA.

Eur J Clin Pharmacol. 2014 Mar;70(3):313-8. doi: 10.1007/s00228-013-1612-7. Epub 2013 Dec 5.

PMID:
24306496
33.

Raising more antibodies.

Ferner R.

BMJ. 2013 Oct 16;347:f5969. doi: 10.1136/bmj.f5969. No abstract available.

PMID:
24133143
34.

On the alert: future priorities for alerts in clinical decision support for computerized physician order entry identified from a European workshop.

Coleman JJ, van der Sijs H, Haefeli WE, Slight SP, McDowell SE, Seidling HM, Eiermann B, Aarts J, Ammenwerth E, Slee A, Ferner RE.

BMC Med Inform Decis Mak. 2013 Oct 1;13:111. doi: 10.1186/1472-6947-13-111. Erratum in: BMC Med Inform Decis Mak. 2013;13:122. Ferner, Robin E [corrected to Slee, Ann]; Slee, Ann [corrected to Ferner, Robin E].

35.

Medical manslaughter.

McDowell SE, Ferner RE.

BMJ. 2013 Sep 18;347:f5609. doi: 10.1136/bmj.f5609. No abstract available.

PMID:
24048308
36.

A bee in the bonnet about honey and healing.

Ferner R.

BMJ. 2013 Aug 15;347:f5015. doi: 10.1136/bmj.f5015. No abstract available.

PMID:
23950196
37.

Hallucination.

Ferner R.

BMJ. 2013 Jul 17;347:f4570. doi: 10.1136/bmj.f4570. No abstract available.

PMID:
23873925
38.

Effects of a computerized feedback intervention on safety performance by junior doctors: results from a randomized mixed method study.

Redwood S, Ngwenya NB, Hodson J, Ferner RE, Coleman JJ.

BMC Med Inform Decis Mak. 2013 Jun 4;13:63. doi: 10.1186/1472-6947-13-63.

39.

Harms from medicines: inevitable, in error or intentional.

Ferner RE.

Br J Clin Pharmacol. 2014 Mar;77(3):403-9. doi: 10.1111/bcp.12156. Review.

40.

Piquancy.

Ferner R.

BMJ. 2013 May 14;346:f2938. doi: 10.1136/bmj.f2938. No abstract available.

PMID:
23674333
41.

A practical guide to monitoring for adverse drug reactions during antihypertensive drug therapy.

McDowell SE, Thomas SK, Coleman JJ, Aronson JK, Ferner RE.

J R Soc Med. 2013 Mar;106(3):87-95. doi: 10.1258/jrsm.2012.120137. Review. Erratum in: J R Soc Med. 2013 Apr;106(4):119.

42.

Divination.

Ferner R.

BMJ. 2013 Mar 7;346:f1536. doi: 10.1136/bmj.f1536. No abstract available.

PMID:
23471365
43.

Beneath the surface.

Ferner R.

BMJ. 2013 Jan 21;346:f380. doi: 10.1136/bmj.f380. No abstract available.

PMID:
23338009
44.

A short history of pharmaceutical marketing.

Ferner R.

BMJ. 2012 Nov 20;345:e7801. doi: 10.1136/bmj.e7801. No abstract available.

PMID:
23169805
45.

Internet accounts of serious adverse drug reactions: a study of experiences of Stevens-Johnson syndrome and toxic epidermal necrolysis.

Butt TF, Cox AR, Oyebode JR, Ferner RE.

Drug Saf. 2012 Dec 1;35(12):1159-70. doi: 10.2165/11631950-000000000-00000.

PMID:
23058037
46.

Susceptibilities.

Ferner R.

BMJ. 2012 Sep 25;345:e6420. doi: 10.1136/bmj.e6420. Review. No abstract available.

PMID:
23014905
47.

Hypoglycemia in non-diabetic in-patients: clinical or criminal?

Nirantharakumar K, Marshall T, Hodson J, Narendran P, Deeks J, Coleman JJ, Ferner RE.

PLoS One. 2012;7(7):e40384. doi: 10.1371/journal.pone.0040384. Epub 2012 Jul 2.

48.

Dose omissions in hospitalized patients in a UK hospital: an analysis of the relative contribution of adverse drug reactions.

Coleman JJ, McDowell SE, Ferner RE.

Drug Saf. 2012 Aug 1;35(8):677-83. doi: 10.2165/11630750-000000000-00000.

PMID:
22734657
49.

Summertime.

Ferner R.

BMJ. 2012 Jun 19;344:e4245. doi: 10.1136/bmj.e4245. No abstract available.

PMID:
22718967
50.

Consequences.

Ferner R.

BMJ. 2012 Apr 20;344:e2859. doi: 10.1136/bmj.e2859. No abstract available.

PMID:
22522707

Supplemental Content

Loading ...
Support Center